MARKET

ACRX

ACRX

Acelrx Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.180
-0.090
-7.09%
Closed 17:06 03/31 EDT
OPEN
1.260
PREV CLOSE
1.270
HIGH
1.260
LOW
1.110
VOLUME
701.52K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
0.7014
MARKET CAP
94.89M
P/E (TTM)
-1.7552
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ACRX stock price target is 6.00 with a high estimate of 9.00 and a low estimate of 2.000.

EPS

ACRX News

More
  • Edited Transcript of ACRX earnings conference call or presentation 16-Mar-20 12:30pm GMT
  • Thomson Reuters StreetEvents · 1d ago
  • All You Need to Know About AcelRx Pharmaceuticals (ACRX) Rating Upgrade to Buy
  • Zacks · 4d ago
  • Acelrx Pharmaceuticals: A New Chapter
  • Seeking Alpha - Article · 6d ago
  • AcelRx Pharmaceuticals, Inc. Just Reported, And Analysts Assigned A US$6.40 Price Target
  • Simply Wall St. · 03/18 11:05

Industry

Biotechnology & Medical Research
-0.49%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Symbol
Price
%Change

About ACRX

AcelRx Pharmaceuticals, Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidates include DSUVIA (known as DZUVEO in Europe) and Zalviso. Its DSUVIA is indicated for use in adults in a certified medically supervised healthcare setting, such as hospitals, surgical centers, and emergency departments, for the management of acute pain. DSUVIA is designed to provide rapid analgesia via a non-invasive route and to eliminate dosing errors associated with IV administration. Its Zalviso is a sufentanil sublingual tablet system intended for the management of moderate-to-severe acute pain in hospitalized adult patients. Zalviso consists of a pre-filled cartridge of 40 sufentanil sublingual tablets, 15 microgram (McG), delivered by the Zalviso System, a needle-free, handheld, patient-administered, pain management system.
More

Webull offers kinds of AcelRx Pharmaceuticals Inc stock information, including NASDAQ:ACRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACRX stock news, and many more online research tools to help you make informed decisions.